Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Combination of lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B.

Trial Profile

Combination of lamivudine and adefovir dipivoxil for treatment of chronic hepatitis B.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Adefovir (Primary) ; Lamivudine (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Apr 2013 Planned end date changed from 1 Sep 2012 to 1 Sep 2013 as reported by ClinicalTrials.gov.
    • 18 May 2010 Planned end date changed from 1 Sep 2006 to 1 Sep 2012 as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual patient number (41) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top